A detailed history of Beaumont Financial Partners, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 11,000 shares of DNA stock, worth $103,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,000
Previous 10,000 10.0%
Holding current value
$103,069
Previous $24,000 41.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $730 - $3,740
1,000 Added 10.0%
11,000 $34,000
Q2 2022

Aug 04, 2022

BUY
$2.2 - $4.2 $22,000 - $42,000
10,000 New
10,000 $24,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Beaumont Financial Partners, LLC Portfolio

Follow Beaumont Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.